Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Telavive
Ofer Merimsky
41 tahun pengalaman
akreditasi :
Klinik telah bersertifikat :
| Israel | Turki | Austria | |
| Terapi sinar proton | dari $48,000 | dari $70,000 | dari $80,000 |
| Prostatektomi da Vinci robotik | dari $24,570 | dari $17,000 | dari $20,000 |
| Operasi kanker paru-paru | dari $27,500 | dari $17,000 | dari $42,000 |
| Operasi Whipple | dari $38,500 | dari $23,000 | dari $45,000 |
| Kemoterapi untuk kanker payudara | dari $22,500 | dari $1,200 | dari $15,000 |
Kepala Unit Onkologi Jaringan Lunak dan Tulang di Sourasky Medical Center – Dr. Merimsky berspesialisasi dalam kasus sarkoma yang kompleks.
Dr. Pelles Sharon berspesialisasi dalam pengobatan adenokarsinoma tingkat lanjut di Sourasky Medical Center, termasuk HIPEC dan imunoterapi.
Dr. Sarid spesialis dalam kemoterapi dan radioterapi dengan lebih dari 25 tahun pengalaman onkologi di Pusat Medis Sourasky (Ichilov) terkemuka di Israel.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.